DIXI medical

What DIXI medical does

DIXI medical is a privately held French medical device company founded in 1970 and headquartered in Marchaux-Chaudefontaine, France, specializing in the design, manufacture, and global distribution of precision intracerebral electrodes for stereo-electroencephalography (SEEG). The company serves neurosurgeons, neurologists, and epileptologists at specialized epilepsy surgery centers that perform procedures on patients with drug-resistant focal epilepsy. With products used in thousands of SEEG procedures annually across more than 40 countries, DIXI medical occupies a focused niche within the functional neurosurgery market. The company employs 51-100 people and operates from clean-room manufacturing facilities in eastern France.

The company's product portfolio centers on the MICRODEEP® family of multi-contact flexi-rigid depth electrodes, available in configurations ranging from 5 to 18 contacts with 0.8 mm diameter platinum/iridium construction. Recent innovations include the MICRODEEP® PIXEL high-resolution electrode for insular and thalamic targeting (15- and 18-contact versions), the MICRODEEP® Micro-Macro electrode for simultaneous population and single-unit neural recordings (CE mark pending), and the SEEG-Tx® proprietary thermocoagulation system with closed-loop automation (FDA 510(k) filed). Supporting the electrodes are IOM cortical electrodes for intraoperative neurophysiological monitoring and a complete range of stereotactic implantation tools, all CE-MDR certified and FDA approved. DIXI medical was the first SEEG electrode company to achieve EU MDR certification.

DIXI medical operates a hybrid go-to-market model. As of October 2025, the company shifted to exclusive direct sales in the United States, ending its distribution agreement with NeuroPace and building a US field team led by a new VP of Sales. Internationally, the company leverages regional distributors including Micromedical in Brazil and Varlix in Mexico, supplemented by direct engagement in select European markets. Revenue is generated primarily through one-time hardware sales of sterile single-use devices priced via quote, with customer relationships sustained through clinical training programs, SEEG education courses in partnership with societies such as ASEPA, and field-based clinical support. The customer base is concentrated among academic and tertiary epilepsy surgery centers, with notable reference accounts including Rush University Medical Center, UCHealth, UC Davis Health, Hospital Niño Jesús in Madrid, Hospices Civils de Lyon, and Hospital das Clínicas de Ribeirão Preto.

Name

DIXI medical

Legal name

DIXI MEDICAL (SAS au capital de 300 000 euros)

Website

https://diximedical.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Short description

DIXI medical is a French medical device company that designs and manufactures precision intracerebral SEEG electrodes and related stereotactic tools for neurosurgeons and neurologists at epilepsy surgery centers in over 40 countries.

Ownership category

akta.pro rank

Product category

Neurosurgical Medical Devices (Intracranial EEG Electrodes)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industry

Epilepsy & Seizure Disorders (HLAKAIAB)

Keywords

• Intracerebral electrodes
• SEEG electrodes
• Neurosurgical medical devices
• Epilepsy surgery devices
• Stereo-electroencephalography equipment

Headquarters

HQ city

Marchaux

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. SEEG Electrodes and Medical Devices: DIXI medical generates revenue through the sale of precision intracerebral electrodes (MICRODEEP® family), cortical monitoring electrodes, implantation tools, and related surgical instruments. Products are sold as sterile single-use devices to epilepsy surgery centers globally. Revenue is primarily one-time purchase based on procedure volume, with recurring customer relationships driven by clinical preference and training investment.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

DIXI medical manufactures and sells precision intracerebral electrodes and accessories for stereo-electroencephalography (SEEG), used to localize epileptogenic zones in patients with drug-resistant epilepsy. Its portfolio includes the MICRODEEP® family of depth electrodes (standard, Micro-Macro, and PIXEL variants), IOM cortical electrodes, stereotactic implantation tools, and the SEEG-Tx® proprietary thermocoagulation system, all delivered as sterile single-use Class III medical devices to neurosurgery teams.

Product overview

DIXI medical offers a comprehensive portfolio of precision medical devices for stereo-electroencephalography (SEEG) in epilepsy care. The core product line centers on MICRODEEP® SEEG electrodes—including standard, Micro-Macro, and PIXEL variants—which are intracerebral depth electrodes for brain signal recording and thermocoagulation. Supporting products include IOM Cortical Electrodes for intraoperative monitoring, a complete range of Implantation Tools (drill bits, guiding screws, stylets), and the SEEG-Tx® proprietary thermocoagulation system. The company has pioneered in developing SEEG technology since the 1970s and holds both CE-MDR and FDA approvals for its electrode products, serving epilepsy centers in over 40 countries.

Differentiator

Problem solved

Functional benefit

Brands

• MICRODEEP®: Multi-contact flexi-rigid intracerebral electrode for SEEG exploration, functional mapping, and epilepsy treatment through thermocoagulation. Features 0.8mm diameter and up to 18 contacts.
• MICRODEEP® PIXEL
• MICRODEEP® Micro-Macro (MME)
• SEEG-Tx®
• IOM Cortical Electrodes

Products and services

• MICRODEEP® SEEG Electrodes

Named customers7 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered former core, regional core, regional key, flagship and key accounts.

• NeuroPaceformer coreChannel Partner/ Reseller/ Distributor · 13 January 2026NeuroPace previously served as DIXI medical's US distribution partner. In January 2026, NeuroPace announced early termination of the DIXI Medical distribution partnership, enabling DIXI medical to reestablish direct sales operations in the United States as of October 1, 2025.
• Micromedical (Brazil)regional coreChannel Partner/ Reseller/ DistributorMicromedical serves as DIXI medical's Brazilian distributor, supporting SEEG training courses and product distribution. Collaborated with DIXI medical to sponsor Dr. Philippe Kahane's participation in Brazilian SEEG training course at Hospital das Clínicas de Ribeirão Preto.
• Varlix (Mexico)regional coreChannel Partner/ Reseller/ DistributorVarlix is DIXI medical's trusted distributor in Mexico, instrumental in navigating regulatory requirements and supporting the first SEEG procedure using DIXI medical electrodes at Hospital Country 2000 in Guadalajara.
• Hospital das Clínicas de Ribeirão Pretoregional keyStrategic or Co-development PartnerHost institution for SEEG training course led by Dr. Philippe Kahane. Organized by Dr. Ameriko Sakamoto with support from DIXI medical and Micromedical. Three cases advanced to SEEG surgeries during the course, demonstrating collaborative clinical education partnership.
• Asian Epilepsy Academy (ASEPA)flagshipStrategic or Co-development PartnerASEPA collaborated with DIXI medical to host the first SEEG course in Asia in Bangkok. This landmark educational event brought together participants from 13 countries, featuring an international faculty of epilepsy experts including Prof. Patrick Chauvel, Prof. Aileen McGonigal, Dr. Jorge Gonzalez-Martinez, and others.
• Epilepsy Society of Thailandregional keyStrategic or Co-development PartnerPartnered with DIXI medical and ASEPA to host the first SEEG course in Asia, contributing to the advancement of SEEG expertise across the Asian region.
• Rush University Medical Centerkey accountsStrategic or Co-development PartnerFirst US clinical site for 18-contact MICRODEEP® PIXEL electrode implantation on February 16, 2026. Dr. Arka Mallela leads epilepsy surgery and brain-mapping programs at the center, representing early adoption partnership for innovation.
• UCHealth University of Colorado Hospitalkey accountsStrategic or Co-development PartnerColorado's first implantation site for 18-contact MICRODEEP® PIXEL electrode on February 20, 2026, led by Dr. Daniel Kramer. Represents leadership in epilepsy treatment and clinical research adoption of advanced SEEG technologies.
• UC Davis Healthkey accountsStrategic or Co-development PartnerUC Davis Health achieved first worldwide implantation of 15-contact MICRODEEP® PIXEL electrode by Dr. David Brandman. Operates largest epilepsy monitoring unit in Northern California and one of California's busiest SEEG programs.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• NeuroPace: NeuroPace developed the RNS® responsive neurostimulation system for drug-resistant epilepsy and previously distributed DIXI medical's electrodes in the US. Its early termination of the DIXI distribution partnership reshaped DIXI's US go-to-market and positions NeuroPace as an adjacent player in the same epilepsy surgery workflow.
• Compumedics: Compumedics designs and manufactures EEG, sleep, and long-term monitoring systems used in epilepsy monitoring units. It is an emerging player in high-density EEG that overlaps with DIXI medical's downstream SEEG workflow and competes indirectly as non-invasive diagnostic tools improve.
• ClearPoint Neuro: ClearPoint Neuro provides MRI-guided neurosurgery navigation and drug delivery systems, intersecting with DIXI medical's robotic stereotactic workflow for SEEG electrode implantation. It is an emerging player in minimally invasive neurosurgery that targets overlapping epilepsy and movement-disorder neurosurgery centers.

Broad incumbents

• Medtronic: Medtronic's Cranial & Spinal Technologies division sells neurosurgical navigation, visualization, and ablation platforms (including Visualase laser ablation) that compete with DIXI medical's SEEG-Tx® thermocoagulation roadmap. Medtronic provided technical support for the first MICRODEEP® PIXEL implantation in Europe, illustrating its broad incumbent role in epilepsy surgery.
• Natus Medical: Natus Medical supplies neurology diagnostic and monitoring equipment (EEG systems, ICU monitoring) used alongside SEEG workflows in epilepsy monitoring units. While not a direct electrode competitor, it is a broad incumbent whose EEG platforms are commonly deployed alongside depth electrodes in DIXI medical's end-customer accounts.
• Integra LifeSciences: Integra LifeSciences owns Ad-Tech Medical (a direct SEEG electrode competitor) and supplies a broad portfolio of neurosurgery instruments and operating-room disposables. It competes with DIXI medical across epilepsy surgery centers via both branded depth electrodes and adjacent neurosurgery tools.

Direct peers

• Inomed Medizintechnik: Inomed makes stereotactic frames, neurostimulation equipment, and accessories used in SEEG/implantation workflows. Its frames (Susy, ZD) are explicitly integrated with DIXI medical's ACS-515C drill, making Inomed an adjacent supplier/partner and a relevant comparable in the neurosurgery workflow ecosystem.
• Ad-Tech Medical: Ad-Tech Medical manufactures intracranial and depth electrodes for SEEG and epilepsy surgery, making it the closest direct competitor to DIXI medical's MICRODEEP® product line. It is now part of Integra LifeSciences, giving the franchise additional commercial scale that DIXI medical competes against in the US and EU.
• PMT Corporation: PMT Corporation manufactures depth electrodes and neurosurgical instruments used in SEEG and intracranial monitoring, competing directly with DIXI medical for epilepsy surgery center share. Its product portfolio overlaps with MICRODEEP® electrodes and implantation accessories.

Others

• Brainlab: Brainlab provides surgical planning, navigation and intra-operative imaging software used during SEEG implantation and epilepsy surgery. It is an ecosystem enabler rather than a direct electrode competitor, but its platforms integrate with the robotic stereotactic workflows where DIXI medical's electrodes are implanted.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCc3ejU47fGXXRqqa1F-G9QQ
• LinkedInlinkedin.com/company/dixi-medical
• Facebookfacebook.com/DIXI-Medical-318392788595249

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIXI medical